IAPP, islet amyloid polypeptide, 3375

N. diseases: 183; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0021670
Disease: insulinoma
insulinoma
0.100 Biomarker disease BEFREE We have identified three cDNA clones encoding islet amyloid polypeptide (IAPP) or diabetes-associated peptide (DAP) by oligonucleotide screening of a lambda gt10 human insulinoma cDNA library. 3053705 1988
Diabetes Mellitus, Non-Insulin-Dependent
0.400 Biomarker disease BEFREE Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. 2690069 1989
Diabetes Mellitus, Non-Insulin-Dependent
0.400 AlteredExpression disease BEFREE Several lines of evidence now implicate elevated amylin levels in the pathogenic mechanisms underlying NIDDM, and suggest to us that the obesity which frequently accompanies this syndrome is a result of, rather than a risk factor for, NIDDM. 2690958 1989
Diabetes Mellitus, Non-Insulin-Dependent
0.400 Biomarker disease BEFREE Amyloid deposits in the islets of Langerhans occur in association with type 2 diabetes mellitus (DM) in humans and cats and consist of a 37-amino-acid polypeptide known as islet amyloid polypeptide (IAPP). 2666169 1989
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.100 GeneticVariation group BEFREE Thus, a species-specific structural motif in the putative amyloidogenic region of IAPP is associated with both amyloid formation and the development of age-related diabetes mellitus. 2670595 1989
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.100 Biomarker group BEFREE Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus. 2690958 1989
Diabetes Mellitus, Insulin-Dependent
0.100 Biomarker disease BEFREE As patients with insulin-treated IDDM frequently experience problems with hypoglycaemia, and as amylin acts to modulate the action of insulin in various tissues, it is possible that amylin deficiency may contribute to morbidity in insulin-treated IDDM, perhaps through the loss of a natural damping mechanism which guards against hypoglycaemia under conditions of normal physiology. 2690958 1989
CUI: C0021670
Disease: insulinoma
insulinoma
0.100 Biomarker disease BEFREE We now report the nucleotide sequences of a human insulinoma cDNA encoding a complete IAPP precursor, and of the corresponding parts of the IAPP gene.Two exons, which are approx. 2651160 1989
CUI: C0028754
Disease: Obesity
Obesity
0.100 AlteredExpression disease BEFREE Several lines of evidence now implicate elevated amylin levels in the pathogenic mechanisms underlying NIDDM, and suggest to us that the obesity which frequently accompanies this syndrome is a result of, rather than a risk factor for, NIDDM. 2690958 1989
CUI: C2936349
Disease: Plaque, Amyloid
Plaque, Amyloid
0.100 Biomarker disease BEFREE Amyloid deposits in the islets of Langerhans occur in association with type 2 diabetes mellitus (DM) in humans and cats and consist of a 37-amino-acid polypeptide known as islet amyloid polypeptide (IAPP). 2666169 1989
CUI: C0020615
Disease: Hypoglycemia
Hypoglycemia
0.020 Biomarker disease BEFREE As patients with insulin-treated IDDM frequently experience problems with hypoglycaemia, and as amylin acts to modulate the action of insulin in various tissues, it is possible that amylin deficiency may contribute to morbidity in insulin-treated IDDM, perhaps through the loss of a natural damping mechanism which guards against hypoglycaemia under conditions of normal physiology. 2690958 1989
Diabetes Mellitus, Non-Insulin-Dependent
0.400 GeneticVariation disease BEFREE We have sequenced the islet amyloid polypeptide precursor coding regions of the gene of 25 patients with Type 2 diabetes. 2258001 1990
Diabetes Mellitus, Non-Insulin-Dependent
0.400 Biomarker disease BEFREE Most evidence to-date suggests that an intrinsic structural motif of IAPP is linked to the amyloidogenicity of IAPP, and that this motif occurs only in those species (e.g., humans and cats) that also develop age-associated or Type 2 diabetes We utilized polymerase chain reaction methodology in this study to obtain the IAPP nucleotide and protein sequences of the dog, a species not known to develop islet amyloid. 2192709 1990
CUI: C0011847
Disease: Diabetes
Diabetes
0.100 Biomarker disease BEFREE The connection between IAPP amyloid formation and diabetes is unknown, but a limited segment of the IAPP molecule, positions 20-29, seems responsible for the aggregation to fibrils. 2195544 1990
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.100 Biomarker group BEFREE The connection between IAPP amyloid formation and diabetes is unknown, but a limited segment of the IAPP molecule, positions 20-29, seems responsible for the aggregation to fibrils. 2195544 1990
Diabetes Mellitus, Insulin-Dependent
0.100 GeneticVariation disease BEFREE Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients. 2258001 1990
CUI: C0021670
Disease: insulinoma
insulinoma
0.100 Biomarker disease BEFREE We show that dog IAPP contains the same putative amyloidogenic sequence (GAILS) at residues 24-28 as human and cat IAPP, and that although dogs do not develop islet amyloid they do develop IAPP-derived amyloid in association with neoplastic beta cells (i.e., insulinomas). 2192709 1990
CUI: C0022336
Disease: Creutzfeldt-Jakob disease
Creutzfeldt-Jakob disease
0.010 Biomarker disease BEFREE This sensitive exogenous strong-stop reaction revealed that CJD infectious fractions contained a series of potential retroviral RNAs including apparent transcripts of endogenous hamster IAP genes. 2108258 1990
Diabetes Mellitus, Non-Insulin-Dependent
0.400 GeneticVariation disease BEFREE A mutation in or near the islet amyloid polypeptide gene is thus unlikely to be a common cause of Type 2 diabetes. 1676684 1991
Diabetes Mellitus, Non-Insulin-Dependent
0.400 GeneticVariation disease BEFREE No differences in the structure of IAPP or its precursor have been found in individuals with maturity-onset diabetes of the young or type II diabetes.(ABSTRACT TRUNCATED AT 250 WORDS) 1999269 1991
CUI: C0011847
Disease: Diabetes
Diabetes
0.100 Biomarker disease BEFREE Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes? 1999269 1991
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.100 Biomarker group BEFREE Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes? 1999269 1991
CUI: C0021670
Disease: insulinoma
insulinoma
0.100 AlteredExpression disease BEFREE IAPP mRNA was confined to the beta-cell phenotype when analyzing the phenotypically stable in vivo tumor lines, MSL-G2-IN (insulinoma) and MSL-G-AN (glucagonoma), and the transgenic mouse islet cell lines, beta-Tc and alpha-Tc. 1850107 1991
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression group BEFREE IAPP mRNA was confined to the beta-cell phenotype when analyzing the phenotypically stable in vivo tumor lines, MSL-G2-IN (insulinoma) and MSL-G-AN (glucagonoma), and the transgenic mouse islet cell lines, beta-Tc and alpha-Tc. 1850107 1991
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.020 Biomarker disease BEFREE Expression of the MIPP gene parallels that of IAP genes in normal mouse tissues with abundant transcripts present in the placenta and also in the myeloma MOPC-315. 1906605 1991